|
CPRX
|
Catalyst Pharmaceutical Partners, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
CERT
|
Certara, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ATRC
|
AtriCure, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
AHCO
|
AdaptHealth Corp.
|
0.03%
|
US
|
NASDAQ
|
|
ADUS
|
Addus HomeCare Corporation
|
0.03%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
0.03%
|
US
|
NASDAQ
|
|
VIR
|
Vir Biotechnology, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ZNTL
|
Zentalis Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
VIVO
|
Meridian Bioscience Inc.
|
0.02%
|
US
|
NASDAQ
|
|
VCEL
|
Vericel Corporation
|
0.02%
|
US
|
NASDAQ
|
|
USPH
|
U.S. Physical Therapy, Inc.
|
0.02%
|
US
|
NYSE
|
|
TWST
|
Twist Bioscience Corporation
|
0.02%
|
US
|
NASDAQ
|
|
TVTX
|
Travere Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
TGTX
|
TG Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
SDGR
|
Schrodinger, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
SAVA
|
Cassava Sciences, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|